We assessed the function of the ␤ C-subunit of activin in hepatocytes. We studied the effect of conditioned medium of Chinese hamster ovary (CHO) cell line stably expressing the ␤ C gene (CHO-␤C) on growth of AML12 hepatocytes. We also examined the effect of recombinant activin C and transfection of the ␤ C gene by using adenovirus vector. CHO-␤C secreted activin C, a homodimer of the ␤C, as well as precursors of the ␤ C. The conditioned medium of CHO-␤C increased both [
follistatin. These results indicate that activin C stimulates growth of AML12 cells. The ␤ C-subunit modifies the function of the ␤A-subunit by multiple mechanisms. activin C; growth; apoptosis ACTIVINS ARE MEMBERS of the transforming growth factor-␤ (TGF-␤) superfamily and elicit diverse actions in various types of cells (21, 29) . Thus they regulate organogenesis and formation of the basic structure of solid organs during development (1, 2, 20) . After birth, activins function as tissue repair factors and are involved in wound healing and regeneration processes of various tissues (12, 15, 19) . They also modulate the immune system (25) and regulate endocrine functions including the hypothalamic-pituitary-gonadal axis (29) .
In the liver, the ␤ A -subunit of activin is expressed mainly in parenchymal cells (28) , and nonparenchymal cells also express a certain amount of the ␤ A -subunit in normal conditions (8) . The ␤ B -subunit of activin is also expressed in the liver, but the expression level is much lower compared with that of the ␤ A -subunit (8) . Activin A, a homodimer of the ␤ A -subunit, is a potent inhibitor of DNA synthesis in hepatocytes (28) . After partial hepatectomy, the expression of the ␤ A -subunit decreases rapidly but is then markedly upregulated 24 to 48 h after hepatectomy (28) . Activin A produced in hepatocytes acts as an autocrine factor and tonically inhibits liver regeneration, as blocking the action of activin A accelerates liver regeneration (15) . It is also critical in maintaining a constant liver mass (13, 16, 17) . Besides its effects on cell growth, activin A also stimulates the production of extracellular matrix proteins and is thought to be involved in the pathogenesis of liver fibrosis (7) .
In addition to the ␤ A -and ␤ B -subunits of activin, two other types of activin subunit, namely ␤ C and ␤ E , are expressed abundantly in the liver (11, 33) . Interestingly, the expression pattern of ␤ C and ␤ E is quite different from that of the ␤ A -subunit in the liver. Under a normal condition, the expression level of the ␤ A -subunit is relatively low, whereas it is markedly increased 24 -48 h after partial hepatectomy (28) . In contrast, the expression level of the ␤ C -and ␤ E -subunits is quite high in normal liver but decreases markedly after partial hepatectomy (9, 11, 19) . The expression pattern is reciprocal to that of the ␤ A -subunit. This raises the possibility that the role of the ␤ C -and ␤ E -subunits of activin, if any, may be different from that of the ␤ A -subunit. However, the function of the ␤ Cor ␤ E -subunit of activin has not been elucidated to date. Recently, Lau et al. (18) generated mutant mice lacking the ␤ C and/or ␤ E gene by a homologous recombination technique. They showed that the liver of the mice lacking the ␤ C and/or ␤ E gene was morphologically normal and that liver regeneration occurred normally after partial hepatectomy. They concluded that the ␤ C -and ␤ E -subunits are dispensable during development and regeneration of the liver (18) . It is not totally certain at present whether or not the ␤ C -and ␤ E -subunits have any specific function in the liver. The present study was conducted to address the function of the ␤ C -subunit of activin in hepatocytes. The results suggest that the ␤ C -subunit has unique functions that are different from those of the ␤ A -subunit.
nal antibody and anti-FLAG M2 affinity gel were purchased from Sigma (St. Louis, MO). Monoclonal anti-␤ A-subunit antibody was described previously (23) . [ 3 H]thymidine and [ 32 P]deoxycytidine triphosphates were purchased from NEN Life Science Products (Boston, MA). Recombinant human activin C was generously provided by Biopharm (Heidelberg, Germany).
Cell culture. AML12 cells were cultured in DMEM-Ham's F-12 supplemented with 10% fetal bovine serum (FBS, GIBCO), ITS solution, 0.1 nM dexamethasone, penicillin, and streptomycin under a humidified atmosphere of 95% air-5% CO 2 at 37°C. They were routinely subcultured using trypsin-EDTA every 5-7 days. Mouse erythroleukemia (F5-5) cells and Chinese hamster ovary (CHO) cells were provided by the Riken Cell Bank (Tsukuba, Japan). These cells were cultured in Ham's F-12 supplemented with 10% FBS, 0.1 nM dexamethasone, penicillin, and streptomycin under a humidified atmosphere of 95% air-5% CO 2 at 37°C.
RNA extraction and Northern blot analysis. Total RNA was extracted from liver homogenates with the TRIzol reagent (Invitrogen). mRNA was extracted using Oligotex-dT30 (Super; Roche) according to the manufacturer's instructions. mRNA was separated by electrophoresis on a 1.0% agarose gel containing 2.2 M formaldehyde and 40 nM MOPS (pH 7.0) and transferred to a nylon membrane (Hybond-Nϩ, Amersham Pharmacia Biotech) by capillary blotting technique with 20ϫ SSC (sodium citrate buffer). Northern blot analyses were performed as described previously (16) , using cDNA for the mouse ␤ C-subunit of activin and cDNA for human glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Clontech, Palo Alto, CA). For quantification of the relative ␤C mRNA content, the intensities of the autoradiographic signals for ␤C and GAPDH were quantified and expressed in arbitrary density units. The ␤C-to-GAPDH ratio (based on integrated signals) was determined for each sample.
Reverse Transcription-PCR. mRNA was isolated from the liver with the TRIzol reagent and Oligotex-dT30 (Super). First-strand cDNA was made from mRNA by use of the Superscript Preamplification System (Invitrogen) according to the manufacturer's instructions. Contaminating genomic DNA was removed with RNase-free DNase. Five micrograms of DNase-treated RNA were incubated with 1 l of oligo(dT) at 70°C for 10 min. Two microliters of 10ϫ PCR buffer, 1 l of DTT (0.1 M), 2 l of dNTP mixture (10 mM), and 2 l of MgCl2 (25 mM) were added to each reaction. After incubation for 5 min at 42°C, 1 l of reverse transcriptase was added. Samples were incubated at 42°C for 50 min and then at 70°C for 15 min. RNase H (1 l) was added to each reaction, and samples were incubated at 37°C for 20 min. PCR was performed as indicated by the manufacturer (Perkin-Elmer, Norwalk, CT) with the following primers: mouse ␤C: a 5Ј end-specific forward primer (5Ј-AAGATGGCCTCCTCCT-TGCTCCTGGCT-3Ј) and a 3Ј end-specific reverse primer (5Ј-AGC-TAACTACACCCGCAGGCCTCGACCA-3Ј). Reactions included 5 l of 10ϫ PCR buffer, 1 l of MgCl2 (50 mM), 1.5 l of dNTP mixture, 1 l of 5Ј primer, 1 l of 3Ј primer, 0.5 l of PLATINUM Pfx DNA polymerase (Invitrogen), and 1 l of cDNA. Samples were incubated at 94°C for 5 min, followed by the indicated number of cycles of 33 s at 94°C, 33 s at 60°C, and 33 s at 72°C, with a final extension at 72°C for 10 min in a Perkin-Elmer DNA thermal cycler.
Recombination procedures and transfection to CHO cells. The mouse cDNA clone was subcloned into the EcoRI site of the vector pcDNA3 (Invitrogen). To introduce the FLAG epitope tag into the carboxyl terminus of the ␤C-subunit of activin, we amplified a fragment of the ␤C by PCR using the sense (5Ј-GGGAATTCCCAC-CATGGCCTCCTCCTTGCTCCTGGCT-3Ј) and the antisense (5Ј-GGGAATTCCTACTTGTCGTCATCGTCTTTGTAGTCCATG-GTACTACACCCGCAGGCCTCGACCA-3Ј) primers; the PCR products were then exchanged for native ␤C cDNA. The PCRgenerated constructs were verified by sequencing the amplified region. The ␤C expression vectors were purified using the Concert High Purify Plasmid Maxiprep System (Invitrogen) according to the manufacturer's instructions. CHO cells were transfected using LipofectAMINE Plus reagent (Invitrogen). To establish stable cell lines, CHO cells were replaced at a density of 2 ϫ 10 5 /well in six-well plates in fresh medium containing 10% FBS at 24 h after transfection. At 48 h after transfection, the transfected cells were selected using 400 g/ml GENETICIN (G418). After 14 days, independent colonies were selected, seeded into 100-mm dishes, and grown to confluence. The cells were screened for a high level of expression of ␤ C and monoclonality by immunostaining and Northern blotting.
Preparation of conditioned medium. Transfected or mock-transfected CHO cells were seeded into 100-mm dishes and grown to subconfluence, at which time 5 ml of ITS and serum free fresh DMEM-F-12 medium were added. After 3 days of further incubation, the conditioned medium was collected, centrifuged to remove floating cells and cell debris, and stored at Ϫ20°C.
To remove follistatin from the conditioned medium, the medium was treated with sulfated cellulofine. After the sulfated cellulofine was washed twice with ice-cold PBS, the conditioned medium was added, incubated at 4°C overnight on a shaker, and centrifuged, and then the supernatant was collected. Sulfated heparin cellulofine was removed by filtering it through a 0.2-m syringe filter.
Recombinant procedures of adenovirus. The cDNA clone for the mouse ␤ C-subunit of activin was subcloned into the cosmid vector (Takara Bio, Tokyo, Japan) with COS-TPC method according to the manufacturer's instructions. Adenovirus vectors were propagated in HEK-293 human embryonic kidney cells transformed by the E1A and E1B genes and titrated with HEK-293 cells. To determine the optimal multiplicity of infection, the adenovirus expressing ␤-galactosidase was transfected.
Bioassay of the activity of activin A. Erythroleukemia (F5-5) cells were seeded at a density of 1 ϫ 10 4 /well in a 96-well plate, with final volumes of 100 l. They were treated with various concentrations of activin A (0.1 to 4 nM) and conditioned medium. After incubation for 5 days at 37°C, 10 l of 1% O-dianisidine (Sigma) were added to stain the differentiated cells.
Measurement of DNA synthesis and cell proliferation. DNA synthesis of AML12 was measured using [ 3 H]thymidine incorporation. Changes in the number of viable cells were determined using 3-(4,5-dimethythiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT), as described by Carmichael et al. (4) . To measure cell growth, the cells were plated at a density of 2 ϫ 10 4 /well in a 24-well plate in DMEM-F-12 medium containing 10% FBS. Six hours later, the cells were serum starved by incubating in serum-free medium for 48 h. The medium was changed every 12 h. To measure DNA synthesis, cells were cultured for 24 h after stimulation, and [ 3 H]thymidine was included for the last 4 h. To measure the changes in the number of cells, cells were cultured with conditioned medium for 48 h. The cells were incubated with MTT for the last 3 h. The lyophilized recombinant human activin C was dissolved in 50% acetonitrile to a final concentration of 10 ng/l.
To study the effect of the recombinant human activin C on the cell growth, the quantity of the acetonitrile was adjusted.
To study the survival of AML12 cells, cells were seeded at a density of 10 4 /well in six-well plates in fresh medium containing 10% FBS. After attachment to the plate, cells were serum starved for 48 h. Then the cells were incubated for 5 days in conditioned medium, and changes in the morphology were observed.
Isolated rat hepatocytes were prepared by collagenase digestion by the method of Berry and Friend (3), and hepatocytes were cultured as described previously (28) . After the completion of attachment to the dish, hepatocytes were incubated in conditioned medium obtained from mock-transfected or ␤C-transfected cells for 48 h. [ 3 H]thymidine was included for the last 24 h. [ 3 H]thymidine incorporation was then measured as described previously (27) .
Binding of 125 I-labeled activin A to receptors and follistatin. Binding of 125 I-labeled activin A to the receptor was measured using AML12 cells, as described previously (30) . In brief, cells were incubated in a 24-well plate with binding buffer containing (in mM) 25 HEPES-NaOH (pH 7.4), 125 NaCl, 5 KCl, 1.2 CaCl2, 5 MgSO4, and 0.5% bovine serum albumin (BSA) at 4°C for 3.5 h in the presence of 0.4 pmol/dish of 125 I-activin A. Nonspecific binding was measured in the presence of 100-fold excess of unlabeled activin A. Binding of 125 I-activin A to follistatin was determined using sulfated cellulofine as described previously (14) . Aliquots (200 l) of standard solution of follistatin were added to glass tubes, and 50 l of sulfated cellulofine gel were added to each tube. After being shaken at room temperature for 24 h, the supernatant was discarded, and the gels were washed three times with 1 ml of assay buffer containing 50 mM Tris ⅐ HCl (pH 7.3), 0.3 mol/l NaCl, 2 mmol/l EDTA, and 0.1% BSA. Thereafter, 125 I-activin A solution was added to each tube with or without unlabeled activin C, and the solution was incubated for 24 h at 4°C. After the incubation, the gels were washed with the washing buffer containing 150 mM NaCl and 0.02% Tween 20, and the radioactivity was counted in a gamma counter.
RESULTS

Effect of conditioned medium of ␤ C -transfected cells on the growth of AML12 cells.
To examine the function of the ␤ Csubunit of activin, we established a permanent cell line expressing a FLAG-tagged ␤ C -subunit (CHO-␤ C cells). The expression of the endogenous ␤ A -or ␤ C -subunit of activin was undetectable in these cells. Morphology and growth rate of CHO-␤ C cells were similar to those in mock-transfected CHO cells (data not shown). The conditioned medium of CHO-␤ C cells contained activin C, a dimer of ␤ C , as well as the precursor (Fig. 1A) . We incubated AML12 cells, a hepatocyte cell line (27) , with the conditioned medium of mock-transfected and ␤ C -transfected cells. As shown in Fig. 1B , conditioned medium obtained from the CHO-␤ C cells significantly increased the cell number, whereas that obtained from mocktransfected cells had no effect. The conditioned medium obtained from CHO-␤ C cells but not from mock-transfected cells also stimulated [ 3 H]thymidine incorporation in AML12 cells (Fig. 1C) . The effect of the CHO-␤ C cell conditioned medium was dependent on its concentration. When activin C was depleted from the conditioned medium by anti-FLAG Affinity gel, the growth-stimulatory effect was markedly inhibited, and the value was not statistically different from the control value (Fig. 1D) . As reported previously, activin A inhibits growth of AML12 cells (32) . The effect of the conditioned medium obtained from CHO-␤ C cells was the opposite of that of activin A. To confirm that the effect of the conditioned medium was independent of the activin A signaling system, we examined the effect of the conditioned medium in AML12 cells expressing the dominant-negative mutant type II activin receptor (AMLtAR cells). In these cells, the effect of activin A was blocked completely, as activin A was trapped by the mutant receptor lacking an intracellular kinase domain (32) . As shown in Fig. 2A , activin A inhibited epidermal growth factor-induced [ 3 H]thymidine incorporation into AML12 cells, whereas it did not elicit any effect in AMLtAR cells, confirming that the activin signaling system was blocked in these cells. In AMLtAR cells, the conditioned medium of CHO-␤ C cells stimulated [ 3 H]thymidine incorporation (Fig. 2B) . It is of note that the conditioned medium did not affect DNA synthesis in Balb/c 3T3 fibroblasts (data not shown).
We then examined whether or not the conditioned medium of CHO-␤ C cells could support the survival of AML12 cells. AML12 cells were seeded sparsely and cultured with serumfree conditioned medium of either mock-transfected or CHO-␤ C cells. Some of the AML cells cultured in the conditioned medium from mock-transfected CHO cells died, and the number of AML12 cells was ϳ75% after 48 h (Fig. 3A) . In contrast, most of the AML12 cells cultured in the conditioned medium of CHO-␤ C cells remained alive. Morphologically, cells cultured in the conditioned medium from ␤ C -transfected CHO cells were different from those cultured in the mocktransfected CHO cell conditioned medium. Cells cultured in conditioned medium obtained from mock-transfected CHO cells shrank after 48 h of culture, and some of them were crenated (Fig. 3Ba) . Note that a similar morphological change was observed in AML12 cells cultured in serum-free medium (data not shown). In contrast, cells cultured in conditioned medium obtained from ␤ C -transfected cells were flat, and some of them displayed extended processes (Fig. 3Bb) .
Effect of conditioned medium of ␤ C -transfected cells on differentiation of erythroleukemia cells. We then examined whether or not the conditioned medium induced erythroid differentiation (10). Activin A induces differentiation of erthroleukemia cells to erythrocytes, and the bioactivity of activin A has been assessed using this cell system (10). The conditioned medium of CHO-␤ C cells did not induce erythroid differentiation by itself (data not shown). However, as shown in Fig. 4A , it markedly inhibited activin A-induced differentiation of erythroleukemia cells. Note that the conditioned medium of mock-transfected cells slightly inhibited the action of activin A on differentiation. This inhibition could have been due to follistatin produced in CHO cells. We therefore treated the conditioned medium of both mock-transfected CHO cells and CHO-␤ C cells with sulfated cellulofine to remove follistatin (13) . As expected, the conditioned medium of mocktransfected cells treated with sulfated cellulofine did not affect activin A-evoked erythroid differentiation (Fig. 4B) . Nonetheless, the conditioned medium of CHO-␤ C cells inhibited the activin A action even after the treatment with sulfated cellolofine, suggesting that the inhibition by the CHO-␤ C conditioned medium was not due to follistatin produced in CHO cells.
Transfection of ␤ C -subunit in AML12 cells with adenovirus vector.
To further assess the function of the ␤ C -subunit, we transfected AML12 cells with cDNA for this subunit by using adenovirus vector. Transfected cells were incubated in serumfree medium, and [ at 48 and 72 h. As shown in Fig. 5A , compared with mocktransfected cells, [ 3 H]thymidine incorporation was significantly higher in cells transfected with the ␤ C -subunit. The expression of the ␤ A -subunit of activin was low in quiescent hepatocytes, but it was upregulated when hepatocytes grew (11, 28, 33) . In contrast, the ␤ C -subunit is abundantly expressed in quiescent cells but was reduced in growing cells (9, 11, 33) . We then examined the expression of the endogenous ␤ C -subunit in AML12 cells. In growing AML12 cells, the expression of the endogenous ␤ C -subunit of activin was not detected by Northern blotting, but in quiescent cells the ␤ Csubunit was abundantly expressed (Fig. 5B) . In contrast, the expression of the endogenous ␤ A -subunit was low in quiescent cells but was higher in growing cells (Fig. 5B) . It was shown in prostate cells that ␤ C -and ␤ A -subunits form a heterodimer (22, 23) . We therefore examined whether or not ␤ C -and ␤ A -subunits form a heterodimer in AML 12 cells. Cells transfected with the FLAG-tagged ␤ C -subunit were incubated with serum-free and serum-containing medium for 24 h. The expression of the endogenous ␤ A -subunit was low and high, respectively, in these conditions. The medium was immunoprecipitated with the anti-FLAG antibody, and Western blotting was done using anti-␤ A -antibody or anti-FLAG antibody. As shown in Fig. 5C , a ␤ A -␤ C heterodimer was detected in the medium when AML12 cells were incubated with serum, in which the expression of the endogenous ␤ A -subunit was detectable. When the expression of the ␤ C -subunit was increased by increasing the titer of the adenovirus vector, the ␤ A -␤ C heterodimer was increased (Fig. 5, C and D) . In contrast, in AML12 cells incubated in serum-free medium, in which the expression of the endogenous ␤ A -subunit was quite low, formation of ␤ A -␤ C heterodimer was not observed. Instead, a homodimer of the ␤ C -subunit was detected (Fig. 5C) .
Effect of recombinant activin C on AML12 cells. We then studied the effect of recombinant human activin C on AML12 cell growth. As shown in Fig. 6A , recombinant activin C, the ␤ C -dimer, stimulated [ 3 H]thymidine incorporation, whereas the recombinant ␤ C -subunit monomer was without effect. Similarly, recombinant activin C, but not the ␤ C monomer, increased the number of cells when incubated in serum-free medium. Recombinant activin C did not affect the binding of 125 I-activin A to the receptor (Fig. 7A) or the binding of 125 I-activin A to follistatin (Fig. 7B) . expression of mRNA for endogenous ␤A-and ␤C-subunits. AML12 cells were incubated for 24 h in medium with (growing) or without (quiescent) 10% FBS, and RNA was extracted. Northern blotting was done to detect mRNA for the ␤A-and ␤C-subunits. C: AML12 cells were transfected with FLAGtagged ␤C-subunit by using adenovirus vector with different multiplicity of infection (MOI). Cells were then incubated for 48 h in the presence or absence of 10% FBS. The medium was obtained and immunoprecipitated with anti-FLAG antibody, and then immunoblotting (IB) was done by using anti-␤A or anti-FLAG antibody. D: AML12 cells were transfected with FLAG-tagged ␤C-subunit by using adenovirus vector at titers of 10 and 50 MOI. Cells were then incubated for 48 h in the presence of 10% FBS. Immunoprecipitation and immunoblotting were done as described. Effect of conditioned medium of ␤ C -transfected cells on DNA synthesis in rat hepatocytes. Finally, we examined the effect of conditioned medium on DNA synthesis in rat hepatocytes in primary culture. DNA synthesis in hepatocytes incubated in conditioned medium obtained from ␤ C -transfected cells was slightly but significantly higher than that in cells incubated in the conditioned medium from mock-transfected cells (Fig. 8) .
DISCUSSION
In the present study, we addressed whether or not activin C has any function in hepatocytes. Because of the limited amount of recombinant activin C available, we employed two alternate approaches to assess the effect of activin C: by testing the effect of transfection of the ␤ C -subunit with an adenovirus vector and by testing the effect of the condition medium obtained from cells stably transfected with the ␤ C -subunit. These different approaches provided essentially similar results.
The conditioned medium obtained from cells expressing the ␤ C -subunit contained a considerable amount of activin C, a ␤ C homodimer. Surprisingly, when added to AML12 cells, it stimulated DNA synthesis and increased the number of cells in serum-free medium. Furthermore, the conditioned medium supported the survival of AML12 cells cultured in a serum-free condition. These effects were the opposite of that of activin A, a ␤ A homodimer. Indeed, the effect was observed in AML12 cells expressing the dominant-negative activin receptor, indicating that activin C can exert its action independently of the activin receptor signaling. A similar stimulatory effect was observed by addition of recombinant activin C. A small stimulatory effect on DNA synthesis was also observed in rat hepatocytes in primary culture. Collectively, unlike activin A, activin C functions as a growth-promoting factor as well as a survival factor in hepatocytes. Perhaps activin C binds to its unique receptor and transmits growth-promoting signals. Elucidation of the putative receptor and the mechanism of action of activin C await further studies.
Besides the action on hepatocytes as a ligand, the ␤ C -subunit also elicits its function by another mechanism, namely formation of a heterodimer with the ␤ A -subunit. Mellor et al. (23) showed that ␤ A -and ␤ C -subunits form a heterodimer in prostate cells. They postulated that the ␤ C -subunit antagonizes activin A by forming a nonfunctioning ␤ A -␤ C subunit (22, 23) . Our results are consistent with their proposal. If the expression of the ␤ C -subunit increases, it would prevent the formation of activin A, a ␤ A homodimer. In normal liver, the expression of the ␤ A -subunit is low, whereas that of ␤ C is quite high. Hence, formation of the growth-inhibitory ␤ A homodimer may be prevented by abundant expression of the ␤ C -subunit in intact liver. Although the function of the ␤ A -␤ C heterodimer is not certain at present, it is perhaps less potent than the ␤ A -␤ A homodimer in inhibiting hepatocyte growth. Again, the ␤ Csubunit functions to attenuate the growth-inhibitory action of the ␤ A -subunit.
Another aspect of ␤ C function was obtained in experiments done in erythroleukemia cells. In these cells, activin A induces erythroid differentiation, and this effect has been used for the bioassay of activin A (10) . In these cells, the conditioned medium from ␤ C -transfected cells, but not from mock-transfected cells, blocked the effect of activin A. Because activin C does not affect the binding of activin A to its receptor, activin C in the conditioned medium may inhibit the activin A signaling at a step distal to the receptor binding. At present, the precise mechanism of the action of activin C is not clear. Identification of the putative receptor for activin C would help to answer this question.
Collectively, these results demonstrate three aspects of the function of the ␤ C -subunit of activin. Intracellularly, it prevents the formation of the ␤ A dimer activin A. Once secreted as a homodimer, activin C stimulates hepatocyte growth by itself. Activin C also attenuates the action of activin A by acting on the postreceptor step. Therefore, the function of the ␤ C -subunit is to antagonize the action of the ␤ A -subunit. In this regard, Lau et al. (18) generated ␤ C -null mice and found no abnor- mality in the liver. Because the activin-follistatin system is very complex, comprising many types of ligands, binding proteins, and receptors, deletion of one or two ligands may have been compensated for by other ligands, including other members of the TGF-␤ superfamily and possibly by other types of growth factors. For example, although activin A exerts numerous effects and regulates cellular functions in various organs (1, 2, 12, 15, 19, 21, 29) , ␤ A -null mice have abnormalities in only limited numbers of organs (6) . Because hepatocyte growth and differentiation are regulated by many growth factors, it is not surprising that the ␤ C -null mice have minimal abnormalities in the liver. Recently, Chabicovsky et al. (5) reported that transfection of the mouse liver with the ␤ Csubunit reduced DNA synthesis in mice. Their results are apparently opposite to ours. They introduced the ␤ C gene by using naked plasmid DNA and measured the regeneration after the damage induced by the gene transfer. They concluded that the ␤ C gene inhibited regenerative DNA synthesis in hepatocytes. The transfection was achieved in only 6% of hepatocytes in the liver. They showed that transfection of the ␤ C reduced the number of bromodeoxyuridine (BrdU) labeling 2 days after transfection. It should be mentioned that the number of BrdUpositive cells peaked 1 day after the gene transfer, and the peak value in ␤ C -transfected mice was comparable to that in LacZtransfected mice. Furthermore, DNA content and the liver weight in ␤ C -transfected mice were not different from those in LacZ-transfected mice. The reduced labeling of BrdU on day 2, therefore, could be explained simply by the phase shift of the DNA synthesis. More importantly, the DNA content and the liver weight in the ␤ C -transfected liver were unchanged, whereas those in the ␤ A -transfected liver were significantly reduced. Consequently, their results rather indicate that the function of the ␤ C is quite different from that of the ␤ A . Vejda et al. (26) recently reported that transfection of the ␤ C -subunit induced apoptosis in Hep G2 cells. As we reported previously (20) , the activin-follistatin system is deranged in many respects in hepatoma cells including Hep G2 cells. Interpretation of data obtained in hepatoma cells should be done carefully.
The present results suggest that the activin-follistatin system in the liver is much more complex than thought previously. The ␤ A -subunit is expressed at relatively low levels in hepatocytes in normal liver. Considering that the ␤ A -and ␤ Csubunits form a heterodimer, activin A, a homodimer of ␤ A , may not be formed in normal liver, since the expression of the ␤ C -subunit is high. Instead, activin C, a homodimer of the ␤ C -subunit, may be formed abundantly in this condition. After partial hepatectomy, the expression of the ␤ C decreases whereas that of the ␤ A is upregulated (9, 33) . This allows the formation of the ␤ A dimer activin A to occur, which participates in termination of the regeneration processes (12, 17) . Then the production of activin A is shut off by both reduction of the ␤ A expression and restoration of the ␤ C expression. Regarding the termination of the activin A action, we need to mention that follistatin, an antagonist of activin A, is also produced in hepatocytes (31) . Indeed, the expression of follistatin is augmented by activin A (6). It is quite likely that follistatin also modifies the effect of activin A during liver regeneration.
In conclusion, the action of the ␤ A dimer activin A is antagonized not only by follistatin but also by a related ligand activin C, a homodimer of the ␤ C -subunit. In the liver, the ␤ E -subunit is also expressed at high levels, and the expression pattern is similar to that of the ␤ C -subunit. Although we do not know the function of ␤ E -subunit at present, the ␤ E -subunit may have its own function. Collectively, the activin-follistatin system may regulate the cells in the liver in a much more complex fashion.
